| Item Type | Name |
|
Academic Article
|
Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
|
|
Academic Article
|
High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation.
|
|
Academic Article
|
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.
|
|
Academic Article
|
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
|
|
Academic Article
|
Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
|
|
Academic Article
|
Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system.
|
|
Concept
|
Granulocytes
|
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
|
Concept
|
Receptors, Granulocyte Colony-Stimulating Factor
|
|
Concept
|
Granulocyte Precursor Cells
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Academic Article
|
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
|
|
Academic Article
|
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.
|
|
Academic Article
|
Serum cholesterol-lowering activity of granulocyte-macrophage colony-stimulating factor.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
|
|
Academic Article
|
Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis.
|
|
Academic Article
|
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
|
|
Academic Article
|
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation: considerations for donors.
|
|
Academic Article
|
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer.
|
|
Academic Article
|
Recombinant human thrombopoietin clinical development.
|
|
Academic Article
|
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors.
|
|
Academic Article
|
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma.
|
|
Academic Article
|
Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
|
|
Academic Article
|
The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial.
|
|
Academic Article
|
Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation.
|
|
Academic Article
|
Humoral stimulation of hemopoietic progenitors from human fetal liver.
|
|
Academic Article
|
Intensive sequential therapy for VAD-resistant multiple myeloma.
|
|
Academic Article
|
Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.
|
|
Academic Article
|
Adverse effects of molgramostim in marrow transplant recipients.
|
|
Academic Article
|
Peripheral blood progenitor cells: a replacement for marrow transplantation?
|
|
Academic Article
|
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures.
|
|
Academic Article
|
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
|
|
Academic Article
|
Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semiautomated density gradient centrifugation in a closed system.
|
|
Academic Article
|
GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
|
|
Academic Article
|
Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia.
|
|
Academic Article
|
Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections.
|
|
Academic Article
|
Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.
|
|
Academic Article
|
Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.
|
|
Academic Article
|
Blood stem cell procurement: donor safety issues.
|
|
Academic Article
|
Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses.
|
|
Academic Article
|
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer.
|
|
Academic Article
|
A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors.
|
|
Academic Article
|
Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development.
|
|
Academic Article
|
Sequential interleukin 3 and granulocyte-macrophage-colony stimulating factor therapy in patients with bone marrow failure with long-term follow-up of responses.
|
|
Academic Article
|
A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis.
|
|
Academic Article
|
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
|
|
Academic Article
|
Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
|
|
Academic Article
|
Bone marrow changes in patients with refractory aplastic anemia treated by recombinant GM-CSF.
|
|
Academic Article
|
Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor.
|
|
Academic Article
|
Aplastic anemia: biology and treatment.
|
|
Academic Article
|
Prevention of graft rejection following bone marrow transplantation.
|
|
Academic Article
|
Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma.
|
|
Academic Article
|
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial.
|
|
Academic Article
|
Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals.
|
|
Academic Article
|
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
|
|
Academic Article
|
Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors.
|
|
Academic Article
|
Collection of peripheral blood stem cells from normal donors 60 years of age or older.
|
|
Academic Article
|
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
|
|
Academic Article
|
Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival.
|
|
Academic Article
|
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
|
|
Academic Article
|
Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.
|
|
Academic Article
|
Primary systemic amyloid light chain amyloidosis decompensating after filgrastim-induced mobilization and stem-cell collection.
|
|
Academic Article
|
Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.
|
|
Academic Article
|
In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin.
|
|
Academic Article
|
Effect of recombinant human granulocyte-macrophage colony-stimulating factor administration on the lymphocyte subsets of patients with refractory aplastic anemia.
|
|
Academic Article
|
Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma.
|
|
Academic Article
|
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges.
|
|
Academic Article
|
Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation.
|
|
Academic Article
|
Granulocyte colony-stimulating factor--primed allogeneic bone marrow transplants: capturing the advantages of blood stem cell transplants without increased risk of chronic graft-versus-host disease.
|
|
Academic Article
|
Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy.
|
|
Academic Article
|
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.
|
|
Academic Article
|
Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation.
|
|
Academic Article
|
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy (Proceedings of the National Academy of Sciences (December 24, 1996) 93 (15346-15351))
|
|
Academic Article
|
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation.
|
|
Academic Article
|
Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study.
|
|
Academic Article
|
Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma.
|